Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -32.24% is 54% above its 5-year average of -69.35%, near the high end of its 5-year range (-104.42%–-31.96%).
42.06% above its 12-month average of -55.64%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -3.98%.
RETURN ON ASSETS (ROA)
-32.24%
RETURN ON ASSETS (ROA) AVG TTM
-55.64%
RETURN ON ASSETS (ROA) AVG 3Y
-73.34%
RETURN ON ASSETS (ROA) AVG 5Y
-69.35%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+42.06%
CURRENT VS 3Y AVG
+56.04%
CURRENT VS 5Y AVG
+53.51%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 855 covered companies
CURRENT VS SECTOR MEDIAN
0.00%
vs the sector median at left
Oculis Holding AG
Market Cap
$494.52M
Return on Assets (ROA)
-32.24%
TTM Avg
-55.64%
3Y Avg
-73.34%
5Y Avg
-69.35%
Market Cap
$502.22M
Return on Assets (ROA)
8.89%
TTM Avg
6.33%
3Y Avg
3.95%
5Y Avg
1.76%
Market Cap
$486.78M
Return on Assets (ROA)
-13.84%
TTM Avg
-22.27%
3Y Avg
-29.75%
5Y Avg
-35.86%
Market Cap
$486.60M
Return on Assets (ROA)
13.86%
TTM Avg
14.29%
3Y Avg
9.48%
5Y Avg
0.09%
Market Cap
$507.01M
Return on Assets (ROA)
-89.18%
TTM Avg
-100.15%
3Y Avg
-92.96%
5Y Avg
-79.13%
Market Cap
$505.65M
Return on Assets (ROA)
-30.08%
TTM Avg
-46.42%
3Y Avg
-46.30%
5Y Avg
-37.15%
Market Cap
$510.79M
Return on Assets (ROA)
-17.46%
TTM Avg
-32.28%
3Y Avg
-24.08%
5Y Avg
-18.67%
Market Cap
$476.63M
Return on Assets (ROA)
-17.49%
TTM Avg
-19.59%
3Y Avg
-24.74%
5Y Avg
-16.53%
Market Cap
$476.10M
Return on Assets (ROA)
-8.14%
TTM Avg
-30.20%
3Y Avg
-72.84%
5Y Avg
-64.85%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $494.52M | -32.24% | -55.64% | -73.34% | -69.35% |
| Tactile Systems Technology, Inc. (TCMD)vs › | $502.22M | 8.89% | 6.33% | 3.95% | 1.76% |
| Evolus, Inc. (EOLS)vs › | $486.78M | -13.84% | -22.27% | -29.75% | -35.86% |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.60M | 13.86% | 14.29% | 9.48% | 0.09% |
| Crescent Biopharma, Inc. (CBIO)vs › | $507.01M | -89.18% | -100.15% | -92.96% | -79.13% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $505.65M | -30.08% | -46.42% | -46.30% | -37.15% |
| 908 Devices Inc. (MASS)vs › | $510.79M | -17.46% | -32.28% | -24.08% | -18.67% |
| Alpha Teknova, Inc. (TKNO)vs › | $476.63M | -17.49% | -19.59% | -24.74% | -16.53% |
| Bright Minds Biosciences Inc. (DRUG)vs › | $476.10M | -8.14% | -30.20% | -72.84% | -64.85% |
| Arvinas, Inc. (ARVN)vs › | $475.20M | 1.38% | -14.74% | -19.98% | -18.10% |
ROA
-32.2%
ROE
-36.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -40.01% |
| 2024-12-31 | -71.27% |
| 2023-12-31 | -77.66% |
| 2022-12-31 | -104.42% |
| 2021-12-31 | -31.96% |
| 2020-12-31 | -90.78% |
